1,2,4,5-Tetrafluoro-3,6-diiodobenzene-2,3-bis(pyridin-2-yl)pyrazine (1/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

Benzoic acid-4-{(1E)-[(E)-2-(pyridin-4-ylmethylidene)hydrazin-1-ylidene]methy l}pyridine (2/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

1,2,4,5-Tetrafluoro-3,6-diiodobenzene-4-(pyridin-4-ylsulfanyl)pyridine (1/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

2-Phenylacetic acid-(E,E)-4,4 `-(hydrazinediylidene)dipyridine(2/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

2-Phenylacetic acid-3-{(E)-2-[(E)-pyridin-3-ylmethylidene]hydrazin-1-ylidenemethyl} pyridine (2/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

2,2 `-(Disulfanediyl)dibenzoic acid-2,9-dimethylphenanthroline-tetrahydrofuran (1/2/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide-benzoic acid (1/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

Benzoic acid-2,9-dimethylphenanthroline (1/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

2-Aminobenzoic acid-4-(pyridin-4-yldisulfanyl)pyridine (1/1) by Arman, H.D., Kaulgud, T., Tiekink, E.R.T.

4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide–1,4-diazabicyclo[2.2.2]octane (2/1) by Hadi D. Arman, Trupta Kaulgud, Edward R. T. Tiekink

Get full text

Benzoic acid-2-{(E)-[(E)-2-(2-pyridylmethylidene)hydrazin-1-ylidene]methyl}p yridine (2/1) by Arman, Hadi D., Kaulgud, Trupta, Tiekink, Edward R.T.

SURGICAL OUTCOMES IN PATIENTS WITH PROXIMAL GASTRIC CANCER WITHOUT ESOPHAGEAL INVASION by F. Sh. Akhmetzyanov, A. H. Kaulgud, F. F. Akhmetzyanova

Get full text

Biological signaling network in myocardial infarction in young adults. A Study of Transcriptome Analysis by Ram S Kaulgud, Gulamnabi L Vanti, S Veeresh, Amruta P Uppar, Mahantesh M Kurjogi

Get full text

Synthesis and Characterization of Multifunctional Chitosan–Silver Nanoparticles: An In-Vitro Approach for Biomedical Applications by Gulamnabi Vanti, Naresh Poondla, Prasath Manogaran, Nagappa Teradal, Veeresh S, Ram Kaulgud, Mahantesh Kurjogi

Get full text

Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial by Ashish Sharma, Anand Zachariah, Pankaj Malhotra, Ashish Jain, Priscilla Rupali, Gajanan Sapkal, Aparna Mukherjee, Vivek Kumar, Lakshmanan Jeyaseelan, Neha Singh, John Victor Peter, Anup Agarwal, Gunjan Kumar, Pranab Chatterjee, Tarun Bhatnagar, B Latha, Sunita Bundas, Ravi Dosi, Rosemarie de Souza, Simmi Dube, B Thrilok Chander, Shalini Bahadur, Amit Suri, Aikaj Jindal, Om Shrivastav, Vijay Barge, Archana Bajpayee, Muralidhar Tambe, Nimisha Sharma, Shreepad Bhat, Anil Gurtoo, D Himanshu Reddy, Kamlesh Upadhyay, Tinkal C Patel, Irfan Nagori, Pramod R Jha, C Aparna, Sunil Jodharam Panjwani, Milind Baldi, M Natarajan, Vrushali Khirid Khadke, Seema Dua, Joy John Mammen, Snehil Kumar, Dolly Daniel, Ravindraa Singh, Jayashree Sharma, Yojana A Gokhale, V Saravana Kumar, Himanshu Kaushal, Lovely Thomas, Jess Elizabeth Rasalam, Binila Chacko, Thenmozhi Mani, Melvin Joy, Malathi Murugesan, Janakkumar R Khambholja, Ram S Kaulgud, K V Sreedhar Babu, Pragya D Yadav

Get full text